Annotation Detail for FGF20

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| Signaling by Insulin receptor |
| Signaling by FGFR |
| Pathway ID | Pathway Name |
|---|
| P00021 | FGF signaling pathway |
| Desease ID | Desease Name |
|---|
| 1709 | Parkinson disease |
| 2053 | Colon cancer |
| Desease Name |
|---|
| Parkinson's disease |
| NEUROLOGICAL |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FGF20 mRNA | affects expression | 16483693
|
| D004390 |
Chlorpyrifos |
Chlorpyrifos results in decreased expression of FGF20 mRNA | decreases expression | 18502319 17589599
|
| D003976 |
Diazinon |
Diazinon results in decreased expression of FGF20 mRNA | decreases expression | 17589599
|
| C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF20 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 12704805
|
| C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF20 protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 12704805
|
| C093973 |
PD 98059 |
PD 98059 results in decreased activity of FGF20 protein | decreases activity | 12704805
|
| D015232 |
Dinoprostone |
FGF20 protein results in increased abundance of Dinoprostone | increases abundance | 12360478
|
| C105686 |
SU 5402 |
SU 5402 results in decreased activity of FGF20 protein | decreases activity | 12704805
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
| MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
5.33 | 17942926 |
| MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
10.76 | 17119214 16611668 11874814 |
| MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
10.76 | 16487989 |
| MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.99 | 10231640 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
6.05 | 10388637 |
| MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
6.16 | 15976003 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
4.42 | 16192471 |
| MESH:D003967 |
Diarrhea |
|
Dinoprostone |
4.93 | 11488427 10446763 7237001 |
| MESH:D004417 |
Dyspnea |
|
Diazinon |
5.32 | 16487989 |
| MESH:D005334 |
Fever |
|
Dinoprostone |
5.18 | 11852909 16997862 |
| MESH:D006505 |
Hepatitis |
|
Diazinon |
4.95 | 16487989 |
| MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
4.78 | 16793879 |
| MESH:D007248 |
Infertility, Male |
|
Diazinon |
4.02 | 12948887 16466525 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
5.69 | 16972261 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
3.13 | 15816358 |
| MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
5.15 | 15991261 |
| MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
5.15 | 15816358 |
| MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
5.64 | 11304026 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
4.37 | 15081274 |
| MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
7.00 | 18500342 |
| MESH:D010300 |
Parkinson Disease |
marker/mechanism |
|
| |
| MESH:D011041 |
Poisoning |
|
Diazinon |
4.70 | 17603234 |
| MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
5.05 | 17119214 16611668 11874814 |
| MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
5.41 | 17119214 16611668 |
| MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
6.61 | 6418539 |
| MESH:D014570 |
Urologic Diseases |
|
Diazinon |
5.80 | 16487989 |
PharmGKB Accession:PA28116
| Releated disease ID |
Related disease Name |
| PA445254 | Parkinson Disease |